NASDAQ:TIL • US45783C2008
Past quarterly earnings results for INSTIL BIO INC (TIL), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -2.01 | -2.38 | 15.49% | 43.22% | - | - | ||
| Q2 2025 | -3.24 | -2.53 | -28.19% | -41.48% | - | - | ||
| Q1 2025 | -4.32 | -2.61 | -65.34% | -15.51% | - | - | ||
| Q4 2024 | -1.82 | -3.25 | 44.04% | 8.54% | - | - | ||
| Q3 2024 | -3.54 | -2.13 | -66.31% | 65.96% | 959.5K | -100.00% | - | |
| Q2 2024 | -2.29 | -3.01 | 23.92% | 18.21% | - | - | ||
| Q1 2024 | -3.74 | -2.25 | -66.05% | 57.50% | - | - | ||
| Q4 2023 | -1.99 | -2.87 | 30.75% | 58.54% | - | - | ||
| Q3 2023 | -10.40 | -2.02 | -414.85% | -20.93% | - | - | ||
| Q2 2023 | -2.80 | -3.30 | 15.13% | 69.57% | - | - | ||
| Q1 2023 | -8.80 | -3.13 | -181.06% | -4.76% | - | - | ||
| Q4 2022 | -4.80 | -8.35 | 42.51% | 44.19% | 505K | -100.00% | - | |
| Q3 2022 | -8.60 | -8.81 | 2.35% | -30.30% | - | - | ||
| Q2 2022 | -9.20 | -8.32 | -10.55% | -70.37% | - | - | ||
| Q1 2022 | -8.40 | -7.74 | -8.48% | 36.36% | - | - | ||
| Q4 2021 | -8.60 | -7.32 | -17.45% | - | - | - | ||
| Q3 2021 | -6.60 | -6.54 | -0.84% | - | - | -100.00% | ||
| Q2 2021 | -5.40 | -4.14 | -30.40% | - | - | -100.00% | ||
| Q1 2021 | -13.20 | -10.45 | -26.27% | - | - | -100.00% | ||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | 50K | - | - | |||
| Q2 2020 | - | - | 40K | - | - | |||
| Q1 2020 | - | - | 40K | - | - |
Notes
INSTIL BIO INC (TIL) last reported earnings on 3/2/2026.
INSTIL BIO INC (TIL) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, INSTIL BIO INC (TIL) has beaten EPS estimates in 2 out of 4 releases.